stockrowMaravai LifeSciences Holdings, Inc. (MRVI) vs Replimune Group, Inc. (REPL)
- Maravai LifeSciences Holdings, Inc. MRVI 7.52 +7.74%
- Replimune Group, Inc. REPL 21.72 +8.49%
Maravai LifeSciences Holdings, Inc. and Replimune Group, Inc. are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Replimune Group, Inc. are of similar size ($1.9B and $1.8B). Replimune Group, Inc. has the higher net margin (0.00% vs −30.8%) and the lower return on invested capital (−928.3% vs −13.6%). Across the 14 metrics below, Maravai LifeSciences Holdings, Inc. leads on 10 and Replimune Group, Inc. on 4.
Valuation
Profitability
| Metric | MRVI | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | 39.15% | 0.00% | 68.51% |
| Operating margin | (45.38%) | 0.00% | 0.00% |
| Net margin | (30.83%) | 0.00% | 0.00% |
| Free cash flow margin | (5.89%) | 0.00% | 0.00% |
| Return on equity | (17.01%) | (115.80%) | (51.96%) |
| Return on assets | (9.06%) | (71.01%) | (46.06%) |
| Return on invested capital | (13.62%) | (928.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack